Efficacy of Standard-Dose Versus Low-Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma—A Retrospective Analysis
PURPOSEAs there is a paucity of data comparing outcomes with different dosing regimens of PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma (R/R HL), this retrospective analysis was undertaken to compare the efficacy of low-dose nivolumab (fixed at 40 mg) with the standard dose of 3 mg/kg.METH...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Clinical Oncology
2026-02-01
|
| Serier: | JCO Global Oncology |
| Online adgang: | https://ascopubs.org/doi/10.1200/GO-25-00424 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
